BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28880986)

  • 1. Association of Disease Location and Treatment With Survival in Diffuse Large B-Cell Lymphoma of the Eye and Ocular Adnexal Region.
    Ahmed AH; Foster CS; Shields CL
    JAMA Ophthalmol; 2017 Oct; 135(10):1062-1068. PubMed ID: 28880986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study.
    Munch-Petersen HD; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Sniegowski MC; Vemuganti GK; Heegaard S
    JAMA Ophthalmol; 2015 Feb; 133(2):165-73. PubMed ID: 25393033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.
    Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
    JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
    Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
    JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse large B-cell lymphoma of the ocular adnexal region: a nation-based study.
    Rasmussen PK; Ralfkiaer E; Prause JU; Sjö LD; Toft PB; Siersma VD; Heegaard S
    Acta Ophthalmol; 2013 Mar; 91(2):163-9. PubMed ID: 22551232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and pathological analysis of ocular adnexal diffuse large B-cell lymphoma].
    Li J; Wang YC; Chen LX; Lin JY
    Zhonghua Yan Ke Za Zhi; 2021 May; 57(5):366-371. PubMed ID: 33915640
    [No Abstract]   [Full Text] [Related]  

  • 8. Ocular adnexal follicular lymphoma: a multicenter international study.
    Rasmussen PK; Coupland SE; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; McKelvie P; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Heegaard S
    JAMA Ophthalmol; 2014 Jul; 132(7):851-8. PubMed ID: 24763920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular adnexal lymphoma: assessment of a tumor-node-metastasis staging system.
    Aronow ME; Portell CA; Rybicki LA; Sweetenham JW; Singh AD
    Ophthalmology; 2013 Sep; 120(9):1915-9. PubMed ID: 23664470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjunctival Lymphoma--An International Multicenter Retrospective Study.
    Kirkegaard MM; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Toft PB; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
    JAMA Ophthalmol; 2016 Apr; 134(4):406-14. PubMed ID: 26891973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ophthalmic lymphoma: epidemiology and pathogenesis.
    Sjö LD
    Acta Ophthalmol; 2009 Feb; 87 Thesis 1():1-20. PubMed ID: 19178392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant lymphomas of the eye].
    Fend F; Süsskind D; Deuter C; Coupland SE
    Pathologe; 2017 Nov; 38(6):515-520. PubMed ID: 28993856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, outcomes, and prognostic factors of orbital lymphoma in the United States.
    Ahmed OM; Ma AK; Ahmed TM; Pointdujour-Lim R
    Orbit; 2020 Dec; 39(6):397-402. PubMed ID: 31894706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and treatment outcomes of diffuse large B-cell lymphoma involving the eye and ocular adnexa in East Asia.
    Han SH; Kim YD; Jang J; Park JW; Young SM; Woo KI
    Acta Ophthalmol; 2021 Nov; 99(7):773-782. PubMed ID: 33421300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific location of ocular adnexal lymphoma and mortality: an international multicentre retrospective study.
    Vest SD; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Hindso TG; Holm F; Honavar SG; Khong JJ; Kirkegaard MK; McKelvie PA; Mikkelsen LH; Mulay K; Rasmussen PK; Siersma V; Sjö LD; Sniegowski MC; Thuro BA; Vemuganti GK; Heegaard S
    Br J Ophthalmol; 2023 Sep; 107(9):1231-1238. PubMed ID: 35512851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
    Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.
    Riemens A; Bromberg J; Touitou V; Sobolewska B; Missotten T; Baarsma S; Hoyng C; Cordero-Coma M; Tomkins-Netzer O; Rozalski A; Tugal-Tutkun I; Guex-Crosier Y; Los LI; Bollemeijer JG; Nolan A; Pawade J; Willermain F; Bodaghi B; ten Dam-van Loon N; Dick A; Zierhut M; Lightman S; Mackensen F; Moulin A; Erckens R; Wensing B; le Hoang P; Lokhorst H; Rothova A
    JAMA Ophthalmol; 2015 Feb; 133(2):191-7. PubMed ID: 25412269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease.
    Hother C; Rasmussen PK; Joshi T; Reker D; Ralfkiær U; Workman CT; Heegaard S; Ralfkiær E; Grønbæk K
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5169-75. PubMed ID: 23821202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
    Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.